毛细血管采血装置市场 - 全球产业规模、份额、趋势、机会及预测（按产品、材料、最终用途、应用、地区和竞争格局划分），2021-2031年

全球毛细血管采血设备市场预计将从 2025 年的 27.2 亿美元成长到 2031 年的 42.7 亿美元，复合年增长率为 7.81%。

这些设备由采血针和微量采血管等无菌器械组成，旨在从指尖、足跟或耳垂等部位采集微量血液，用于诊断目的。它们在微创即时诊断测试和患者自我管理中发挥着至关重要的作用。市场成长的主要驱动力是全球慢性病负担日益加重，这些疾病需要频繁监测，以及医疗服务向分散化模式的广泛转变。需要定期后续观察的疾病的高发生率凸显了这种日益增长的需求；例如，国际糖尿病联盟估计，到2024年，全球将有5.89亿成年人患有糖尿病。

儘管存在这些市场驱动因素，但与静脉采血相比，毛细血管采血在检体量和检体完整性方面仍面临许多挑战。毛细血管检体容易出现溶血和组织液污染等分析前问题，这些问题会影响诊断准确性。这些技术限制使得毛细血管采血难以应用于需要更大样本量和更高品质检体的复杂检测。因此，医疗机构往往必须依赖传统的静脉穿刺进行全面的临床评估，从而有效地阻碍了毛细血管采血替代静脉采血的进程。

市场驱动因素

全球感染疾病的日益普及是毛细血管采血装置市场的主要驱动力，尤其推动了对指尖采血快速诊断检测的需求。这些微创装置对于资源匮乏地区的大规模筛检计画至关重要，因为在这些地区，传统的静脉采血往往成本高昂或操作难度高。在媒介传播感染疾病的防治中，毛细血管血横向流动化验被广泛用于即时确诊和监测。感染带来的巨大负担也凸显了这种高度依赖性。根据世界卫生组织（世卫组织）发布的《2023年世界疟疾报告》，预计2022年全球疟疾病例将达到2.49亿例，这一数字直接印证了安全采血针和微型采血管的高使用率。

同时，就地检验和分散式诊断的兴起正在从根本上改变毛细血管采血设备的消费趋势。医疗系统正在加速从集中式检查室向非现场筛检检测的转变，以改善患者就医途径并加快临床决策，从而推动了对便捷采血试剂盒的需求激增。这项转变的背后是解决病毒性疾病诊断缺口的迫切性。根据世界卫生组织（世卫组织）发布的《2024年全球肝炎报告》，仅有36%的C型肝炎病例被诊断，凸显了普及毛细血管筛检检测的迫切需求。支持这些工作的产业规模庞大，贝克顿‧迪金森公司（Becton, Dickinson & Company）2023年生命科学部门51.3亿美元的营收便印证了这一点。

市场挑战

全球毛细血管采血装置市场成长的主要障碍在于毛细血管采样固有的样本完整性问题和有限的采血量。与静脉采血不同，由于采集过程中需要对组织进行压迫，毛细血管采血更容易发生溶血和组织间液污染。这些分析前缺陷会显着降低检体质量，导致检体常常不适用于需要高精度和大检体量的高灵敏度临床检测。因此，医疗机构往往不愿将这些装置用于全面的诊断检测，而主要将其应用限制在血糖监测和基础筛检。

这些技术挑战阻碍了毛细血管采血系统在临床应用中完全取代传统的静脉穿刺，直接限制了市场扩张。由于诊断准确性可能降低，检查室被迫拒绝受损检体，导致需要重复采血，加重患者负担并增加营运成本。近期产业数据凸显了这个问题的严重性。根据ECRI 2024报告，约23%的诊断错误与技术或处理失误（包括检体品质问题）有关。如此高的错误率，加上检体处理不当，使得医护人员在进行关键医疗决策时，对全面采用毛细血管采血系统持谨慎态度。

市场趋势

真空辅助上臂采血装置的兴起代表着市场的一项重大进步，有效克服了传统指尖采血在样本量和品质方面的限制。与依赖组织压迫的传统采血针不同，这些创新装置利用负压从上臂毛细血管采集血液，从而能够获得与静脉采血相当的大量检查室级检体。这项功能推动了血液采集方式从以诊所为基础向以患者为中心的远端采血模式转变，尤其适用于需要超出标准毛细血管采血能力的血清或血浆样本的慢性病检测。该技术的商业性成功体现在其快速普及上。 Tasso在2025年3月的新闻稿中宣布，其将售出超过150万台以患者为中心的装置，这标誌着该方法在远距离诊断领域正日益被接受。

同时，体积吸收微量采样（VAMS）技术的整合正在革新干血采样方法，消除了传统滤纸法中通用的血球比容偏差。 VAMS设备能够采集固定且精确的血液量，不受血液黏度的影响，从而确保治疗药物监测和药物研发所需的定量分析的准确性。这项技术进步使製药公司能够在分散式临床试验中采用远端采样，同时保持数据完整性，提高受试者的保留率和可及性。产业绩效也印证了这种精准方法的经济可行性。 Trajan集团控股有限公司在其2025年2月的财务报告中宣布，其负责微量采样产品系列的「创新技术事业部」上半年营收达220万美元，证实了市场对这些先进解决方案的持续需求。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球毛细血管采血装置市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 副产品（采血针、微型采血管、微型血球比容管、加温装置、其他）
  • 依材质（塑胶、玻璃、不锈钢、陶瓷等）
  • 依应用领域（医院/诊所、捐血中心、诊断中心、家庭诊断、病理检查室）
  • 依应用题项（全血、血浆/血清蛋白检测、综合代谢指标（CMP）检测、肝功能检测/肝功能分析/肝功能检查、干血斑检测）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美毛细血管采血设备市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

第七章 欧洲毛细血管采血装置市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章 亚太地区毛细血管采血设备市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲毛细血管采血装置市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲毛细血管采血装置市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球毛细血管采血设备市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Becton, Dickinson and Company
• Greiner Bio-One International GmbH
• Sarstedt Ag & Co. KG
• Terumo Medical Corporation
• B. Braun Melsungen AG
• Guangzhou Improve Medical Instruments Co., Ltd
• Abbott Laboratories Inc.
• Cardinal Health, inc
• Retractable Technologies, Inc.
• Haemonetics Corporation

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Capillary Blood Collection Devices Market is projected to expand from a valuation of USD 2.72 billion in 2025 to USD 4.27 billion by 2031, reflecting a compound annual growth rate of 7.81%. These devices, comprising sterile tools like lancets and micro-collection tubes, are engineered to extract minute blood volumes from sites such as the fingertip, heel, or earlobe for diagnostic purposes. They play a pivotal role in minimally invasive point-of-care testing and patient self-management routines. Market momentum is primarily sustained by the escalating global burden of chronic conditions that demand frequent monitoring, alongside a broader shift toward decentralized healthcare services. This increasing demand is highlighted by the sheer prevalence of diseases requiring regular tracking; for instance, the International Diabetes Federation estimated that 589 million adults globally were living with diabetes in 2024.

Despite these drivers, the market encounters substantial obstacles related to sample volume limitations and integrity when compared to venous collection methods. Capillary samples are prone to pre-analytical complications, including hemolysis and contamination by interstitial fluid, which can negatively impact diagnostic precision. These technical constraints limit the applicability of capillary collection for complex assays that necessitate larger, high-quality samples. Consequently, healthcare providers are often forced to rely on traditional venipuncture for comprehensive clinical assessments, effectively preventing the complete replacement of venous blood draws with capillary alternatives.

Market Driver

The escalating prevalence of infectious diseases worldwide acts as a major engine for the capillary blood collection devices market, particularly by driving the need for rapid diagnostic tests capable of using finger-prick samples. These minimally invasive instruments are indispensable for mass screening programs in resource-constrained environments where traditional venous draws are often too expensive or logistically difficult. Management of vector-borne diseases relies heavily on lateral flow assays using capillary blood for immediate confirmation and monitoring. The scale of this dependency is evidenced by the massive burden of infection; the World Health Organization's 'World Malaria Report 2023' estimated 249 million global malaria cases in 2022, a figure that directly supports the high-volume use of safety lancets and micro-collection tubes.

Simultaneously, the proliferation of point-of-care testing and decentralized diagnostics is fundamentally altering consumption trends for capillary devices. Healthcare systems are increasingly moving screening procedures out of central labs to enhance patient access and speed up clinical decisions, resulting in a surge in demand for simplified collection kits. This shift is motivated by the critical need to address diagnostic gaps in viral diseases; the World Health Organization's 'Global Hepatitis Report 2024' noted that only 36% of individuals with hepatitis C had been diagnosed, underlining a significant need for accessible capillary-based screening. The industry supporting these efforts operates on a massive scale, as demonstrated by Becton, Dickinson and Company, which reported $5.13 billion in revenue for its Life Sciences segment in 2023.

Market Challenge

The central hurdle inhibiting the growth of the Global Capillary Blood Collection Devices Market involves persistent difficulties regarding sample integrity and restricted volume inherent in capillary sampling. In contrast to venous draws, capillary blood is significantly more susceptible to hemolysis and interstitial fluid contamination caused by the tissue compression necessary during collection. These pre-analytical defects severely degrade specimen quality, frequently making samples inadequate for sensitive clinical assays that require high precision and larger volumes. As a result, medical providers often hesitate to utilize these devices for comprehensive diagnostic panels, limiting their application primarily to glucose monitoring and basic screening.

These technical shortcomings directly obstruct market expansion by precluding the total replacement of traditional venipuncture in clinical environments. The potential for diagnostic inaccuracy compels laboratories to reject compromised samples, leading to repeated draws that elevate patient discomfort and operational expenses. The gravity of this issue is highlighted by recent industry data; according to ECRI in 2024, roughly 23% of diagnostic errors were linked to technical or processing failures, including specimen quality issues. Such high error rates associated with improper sample handling reinforce the reluctance of medical professionals to fully transition to capillary collection systems for critical healthcare decisions.

Market Trends

The rise of Vacuum-Assisted Upper Arm Collection Devices marks a significant market advancement, effectively mitigating the historical limitations regarding volume and quality associated with fingerstick sampling. Distinct from traditional lancets that depend on tissue compression, these innovative devices apply negative pressure to extract capillary blood from the upper arm, yielding larger, lab-quality specimens comparable to venous draws. This functionality supports a structural shift from clinic-based phlebotomy toward patient-centric remote collection, specifically for chronic disease panels needing serum or plasma volumes beyond standard capillary capabilities. The commercial success of this technology is reflected in its rapid adoption; Tasso, Inc. announced in a March 2025 press release that it had sold over 1.5 million of its patient-centric devices, signaling growing acceptance of this method for remote diagnostics.

In parallel, the integration of Volumetric Absorptive Microsampling (VAMS) Technology is transforming dried blood sampling by eliminating the hematocrit bias common in traditional filter paper techniques. VAMS devices capture a fixed, precise blood volume regardless of viscosity, guaranteeing analytical accuracy for quantitative assays essential to therapeutic drug monitoring and pharmaceutical development. This technological improvement enables pharmaceutical firms to incorporate remote sampling into decentralized clinical trials while maintaining data integrity, thereby enhancing participant retention and access. The financial viability of this precise approach is evidenced by sector performance; Trajan Group Holdings Limited reported in its February 2025 financial results that its Disruptive Technologies segment, housing the microsampling portfolio, achieved $2.2 million in half-year revenue, confirming sustained demand for these advanced solutions.

Key Market Players

• Becton, Dickinson and Company
• Greiner Bio-One International GmbH
• Sarstedt Ag & Co. KG
• Terumo Medical Corporation
• B. Braun Melsungen AG
• Guangzhou Improve Medical Instruments Co., Ltd
• Abbott Laboratories Inc.
• Cardinal Health, inc
• Retractable Technologies, Inc.
• Haemonetics Corporation

Report Scope

In this report, the Global Capillary Blood Collection Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Capillary Blood Collection Devices Market, By Product

• Lancets
• Micro-container Tubes
• Micro-hematocrit Tubes
• Warming Devices
• Others

Capillary Blood Collection Devices Market, By Material

• Plastic
• Glass
• Stainless Steel
• Ceramic
• Others

Capillary Blood Collection Devices Market, By End Use

• Hospitals & Clinics
• Blood Donation Centers
• Diagnostic Centers
• Home Diagnosis
• Pathology Laboratories

Capillary Blood Collection Devices Market, By Application

• Whole Blood
• Plasma/ Serum Protein Tests
• Comprehensive Metabolic Panel (CMP) Tests
• Liver Panel / Liver Profile/ Liver Function Tests
• Dried Blood Spot Tests

Capillary Blood Collection Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Capillary Blood Collection Devices Market.

Available Customizations:

Global Capillary Blood Collection Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Capillary Blood Collection Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Lancets, Micro-container Tubes, Micro-hematocrit Tubes, Warming Devices, Others)
  • 5.2.2. By Material (Plastic, Glass, Stainless Steel, Ceramic, Others)
  • 5.2.3. By End Use (Hospitals & Clinics, Blood Donation Centers, Diagnostic Centers, Home Diagnosis, Pathology Laboratories)
  • 5.2.4. By Application (Whole Blood, Plasma/ Serum Protein Tests, Comprehensive Metabolic Panel (CMP) Tests, Liver Panel / Liver Profile/ Liver Function Tests, Dried Blood Spot Tests)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Capillary Blood Collection Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Material
  • 6.2.3. By End Use
  • 6.2.4. By Application
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Capillary Blood Collection Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Material
      • 6.3.1.2.3. By End Use
      • 6.3.1.2.4. By Application
  • 6.3.2. Canada Capillary Blood Collection Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Material
      • 6.3.2.2.3. By End Use
      • 6.3.2.2.4. By Application
  • 6.3.3. Mexico Capillary Blood Collection Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Material
      • 6.3.3.2.3. By End Use
      • 6.3.3.2.4. By Application

7. Europe Capillary Blood Collection Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Material
  • 7.2.3. By End Use
  • 7.2.4. By Application
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Capillary Blood Collection Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Material
      • 7.3.1.2.3. By End Use
      • 7.3.1.2.4. By Application
  • 7.3.2. France Capillary Blood Collection Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Material
      • 7.3.2.2.3. By End Use
      • 7.3.2.2.4. By Application
  • 7.3.3. United Kingdom Capillary Blood Collection Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Material
      • 7.3.3.2.3. By End Use
      • 7.3.3.2.4. By Application
  • 7.3.4. Italy Capillary Blood Collection Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Material
      • 7.3.4.2.3. By End Use
      • 7.3.4.2.4. By Application
  • 7.3.5. Spain Capillary Blood Collection Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Material
      • 7.3.5.2.3. By End Use
      • 7.3.5.2.4. By Application

8. Asia Pacific Capillary Blood Collection Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Material
  • 8.2.3. By End Use
  • 8.2.4. By Application
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Capillary Blood Collection Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Material
      • 8.3.1.2.3. By End Use
      • 8.3.1.2.4. By Application
  • 8.3.2. India Capillary Blood Collection Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Material
      • 8.3.2.2.3. By End Use
      • 8.3.2.2.4. By Application
  • 8.3.3. Japan Capillary Blood Collection Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Material
      • 8.3.3.2.3. By End Use
      • 8.3.3.2.4. By Application
  • 8.3.4. South Korea Capillary Blood Collection Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Material
      • 8.3.4.2.3. By End Use
      • 8.3.4.2.4. By Application
  • 8.3.5. Australia Capillary Blood Collection Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Material
      • 8.3.5.2.3. By End Use
      • 8.3.5.2.4. By Application

9. Middle East & Africa Capillary Blood Collection Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Material
  • 9.2.3. By End Use
  • 9.2.4. By Application
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Capillary Blood Collection Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Material
      • 9.3.1.2.3. By End Use
      • 9.3.1.2.4. By Application
  • 9.3.2. UAE Capillary Blood Collection Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Material
      • 9.3.2.2.3. By End Use
      • 9.3.2.2.4. By Application
  • 9.3.3. South Africa Capillary Blood Collection Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Material
      • 9.3.3.2.3. By End Use
      • 9.3.3.2.4. By Application

10. South America Capillary Blood Collection Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Material
  • 10.2.3. By End Use
  • 10.2.4. By Application
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Capillary Blood Collection Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Material
      • 10.3.1.2.3. By End Use
      • 10.3.1.2.4. By Application
  • 10.3.2. Colombia Capillary Blood Collection Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Material
      • 10.3.2.2.3. By End Use
      • 10.3.2.2.4. By Application
  • 10.3.3. Argentina Capillary Blood Collection Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Material
      • 10.3.3.2.3. By End Use
      • 10.3.3.2.4. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Capillary Blood Collection Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Becton, Dickinson and Company
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Greiner Bio-One International GmbH
• 15.3. Sarstedt Ag & Co. KG
• 15.4. Terumo Medical Corporation
• 15.5. B. Braun Melsungen AG
• 15.6. Guangzhou Improve Medical Instruments Co., Ltd
• 15.7. Abbott Laboratories Inc.
• 15.8. Cardinal Health, inc
• 15.9. Retractable Technologies, Inc.
• 15.10. Haemonetics Corporation

16. Strategic Recommendations

17. About Us & Disclaimer